Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease-Reference-Cited by-同舟云学术

Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease

Published:2024-04-29 Issue:5 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Natale Patrizia¹²³,Palmer Suetonia C⁴,Navaneethan Sankar D⁵,Craig Jonathan C⁶⁷,Strippoli Giovanni FM¹³⁶

Affiliation:

1. Sydney School of Public Health; The University of Sydney; Sydney Australia

2. Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences; University of Foggia; Foggia Italy

3. Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J); University of Bari Aldo Moro; Bari Italy

4. Department of Medicine; University of Otago Christchurch; Christchurch New Zealand

5. Baylor College of Medicine; Houston Texas USA

6. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

7. College of Medicine and Public Health; Flinders University; Adelaide Australia

Publisher

Wiley

Reference688 articles.

1. Effects of a calcium channel antagonist versus an ACE inhibitor on diabetic nephropathy [abstract no: S1064];Estacio;Journal of the American Society of Nephrology,1998

2. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes;Estacio;Diabetes Care,2000

3. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension;Estacio;New England Journal of Medicine,1998

4. Aggressive lowering of blood pressure in normotensive type 2 diabetic patients: beneficial effects on stroke, progression of retinopathy and nephropathy [abstract no: A0763];Estacio;Journal of the American Society of Nephrology,2001

5. Baseline characteristics of participants in the Appropriate Blood pressure Control in Diabetes trial;Estacio;Controlled Clinical Trials,1996